Haemonetics Corp. buy BTIG Research
Start price
10.09.24
/
50%
€66.50
Target price
10.09.25
€101.52
Performance (%)
-32.03%
End price
11.09.25
€45.20
Summary
This prediction ended on 11.09.25 with a price of €45.20. The BUY prediction by BTIG_Research for Haemonetics Corp. performed very badly with a performance of -32.03%. BTIG_Research has a follow-up prediction for Haemonetics Corp. where he still thinks Haemonetics Corp. is a Buy. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Haemonetics Corp. | 5.426% | 5.426% | - |
| iShares Core DAX® | -1.358% | -2.329% | 3.438% |
| iShares Nasdaq 100 | -3.700% | -1.242% | 33.079% |
| iShares Nikkei 225® | -2.512% | 6.914% | 60.778% |
| iShares S&P 500 | -1.662% | -0.643% | 23.467% |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
In the thread Trading Haemonetics Corp.
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten
Current prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
18.26%
26.06.26
26.06.26
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€48.40
06.02.26
06.02.26
€74.64
06.02.27
06.02.27
40.50%
26.06.26
26.06.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€72.00
09.01.26
09.01.26
€75.54
09.01.27
09.01.27
-5.56%
26.06.26
26.06.26